Potentially most just like IGC regarding solution candidates and an early-phase pipeline is Zynerba Prescribed drugs, Inc. (NASDAQ: ZYNE), a medical-phase pharmaceutical firm engaged in developing revolutionary transdermal artificial cannabinoid treatment method for clients who definitely have higher unmet health-related requires. As of July 18, Zy… Read More